What Causes High Alkaline Phosphatase in a Child?

The single most common reason a child’s alkaline phosphatase (ALP) is high is perfectly normal bone growth. ALP is an enzyme released by active bone-forming cells, so children who are growing rapidly, especially infants and adolescents going through puberty, can have ALP levels that look alarmingly high compared to adult reference ranges. Beyond normal growth, a long list of conditions can push the number higher, from a harmless temporary spike triggered by a viral infection to liver disease, vitamin D deficiency, kidney problems, and, rarely, bone tumors. Knowing which scenario fits a particular child depends on age, symptoms, and a few follow-up tests.

Why Growing Children Have Higher ALP Than Adults

ALP is closely tied to bone metabolism. The bone form of the enzyme helps deposit minerals into growing bone, so the more actively a child’s skeleton is expanding, the more ALP shows up in the blood. A study tracking healthy children found that ALP peaks in the first six months of life, settles to a relatively steady level through middle childhood, and then climbs again around ages nine to fifteen as puberty kicks in. In boys, levels exceeding 900 U/L were seen in several age windows from infancy through mid-adolescence. In girls, similarly high values appeared in the first six months and again around ages twelve to thirteen.¹ Those numbers would prompt an immediate investigation in an adult, but in a child they can be entirely physiological.

The sex differences matter. Boys and girls track closely until about age ten, when girls briefly run higher because they tend to enter puberty earlier. After around twelve, girls’ levels start declining while boys’ values keep climbing, sometimes not settling near adult ranges until age sixteen to eighteen.¹ This is why pediatric labs need age- and sex-specific reference intervals rather than a single adult cutoff. A German population-based study confirmed that continuous, growth-phase-adjusted reference values are essential for interpreting ALP in children.²

Benign Transient Hyperphosphatasemia

If a toddler’s blood work comes back showing ALP in the thousands and no one can figure out why, there is a good chance the child has benign transient hyperphosphatasemia (BTH). This is a temporary, harmless spike in ALP that mainly hits children under five. The enzyme shoots up, sometimes dramatically, and then drifts back to normal on its own within a few months. In one case series, the mean time for ALP to normalize was about two and a half months, and every child’s levels returned to normal within four months without any treatment.³

BTH tends to show up in children between about four months and two years old. A Korean study of nearly a hundred cases found that the most common associated illness at the time of the spike was a respiratory tract infection, followed by acute gastroenteritis. When the ALP was rechecked a month later, it had already dropped below 1,000 U/L in about 84 percent of cases.⁴ BTH should be considered whenever a child under five has a severely elevated ALP but no clinical signs or lab evidence of bone or liver disease.⁵

The practical takeaway for parents: if the child looks well, the liver tests are otherwise normal, and there are no bone abnormalities, a “wait and recheck” approach is usually the right call. One published algorithm for pediatric elevated ALP explicitly recommends this strategy, noting that a healthy child with an isolated ALP elevation that normalizes within a few months fits the BTH pattern and needs no further workup.⁶

Viral Infections as a Trigger

Researchers have noticed that BTH often clusters around viral illness seasons, and some have tried to pin down which viruses might be responsible. One study found that ten out of eleven children with transient hyperphosphatasemia had acute respiratory infections at the time.⁷ A separate investigation looked for viral antibodies in children with BTH and found a wide range of enterovirus antibodies in their serum, including echoviruses, Coxsackie B viruses, and enterovirus 71, suggesting that common childhood viruses may trigger the ALP spike in susceptible kids.⁸ Twins with BTH in that study became sick at the same time, reinforcing the idea of an infectious trigger rather than a metabolic one.

The mechanism is not completely understood, but the working theory involves a viral illness stimulating a brief surge in ALP production, possibly from both bone and liver isoenzymes, that resolves once the immune response settles. For parents, the connection to recent illness can be reassuring: if your child’s ALP was drawn during or shortly after a cold or stomach bug, the elevation may simply be a temporary side effect of fighting off an infection.

Rickets and Other Bone Disorders

When a child’s bones are not mineralizing properly, ALP rises because the bone-forming cells are working overtime trying to compensate. ALP’s biological job is to increase the ratio of inorganic phosphate to pyrophosphate, removing a natural inhibitor of mineralization. The bone-specific form of the enzyme reflects osteoblast activity and is considered a marker of bone turnover.⁹

Rickets, caused by vitamin D deficiency, calcium deficiency, or phosphate wasting, is the classic bone condition that drives ALP up in children. A child with rickets often has bowing of the legs, widened wrists, delayed motor milestones, and very high ALP along with low vitamin D or abnormal calcium and phosphorus levels. In countries where vitamin D deficiency remains prevalent, rickets is one of the first diagnoses clinicians consider when a child’s ALP is elevated.

Less commonly, genetic forms of phosphate wasting or other metabolic bone diseases can present the same way. In all of these situations, the ALP elevation is a signal that bone turnover is abnormally high and that the underlying mineral supply problem needs to be addressed.

Liver and Bile Duct Problems

ALP is not just a bone enzyme. A different form of it lines the bile ducts in the liver, and anything that obstructs bile flow or damages liver tissue can push the total ALP up. In infants, cholestasis (a condition where bile does not flow properly) is an important cause. A study of infants with cholestasis found that median ALP levels were roughly six times higher than in healthy controls, regardless of whether the obstruction was inside the liver or outside it.¹⁰

One complication in interpreting ALP in liver disease is that the high level does not always mean what you think. A classic study of children with hepatobiliary disease found that the elevated ALP was unrelated to the presence or absence of bone disease in those patients, meaning you cannot assume a high ALP in a child with known liver problems is entirely from the liver.¹¹ Similarly, research on infants receiving long-term intravenous nutrition who develop liver disease found that their elevated ALP was predominantly of bone origin rather than liver origin, likely reflecting metabolic bone disease from poor mineral intake.¹² The upshot: when both bone and liver disease are possible, an ALP isoenzyme test or additional markers like GGT (gamma-glutamyl transferase) help sort out where the elevation is coming from.

Celiac Disease and Malabsorption

Celiac disease has an interesting two-sided relationship with ALP. On one hand, the disease damages the intestinal lining, and research shows that the intestinal form of alkaline phosphatase is decreased in the gut tissue of children with active celiac disease. That enzyme plays a role in gut barrier integrity, and its levels normalize once a child starts a gluten-free diet.¹³ On the other hand, the malabsorption caused by celiac disease can deplete calcium and vitamin D, leading to secondary rickets and a rise in the bone isoenzyme of ALP in the blood. So a child with undiagnosed celiac disease might show up with a high serum ALP not because the intestinal enzyme is elevated but because their bones are mineral-starved. The original demonstration of decreased intestinal ALP in celiac biopsy tissue dates back decades.¹⁴

Chronic Kidney Disease

Children with chronic kidney disease (CKD) develop a complex disturbance in mineral and bone metabolism. The kidneys normally activate vitamin D and regulate phosphorus excretion; when they fail, secondary hyperparathyroidism develops, driving up bone turnover and ALP. In children on dialysis, both parathyroid hormone and ALP are positively associated with bone turnover, though neither marker alone is highly sensitive or specific for predicting exactly what is happening inside the bone.¹⁵

A bone-specific ALP test can help clinicians assess bone turnover more accurately in these children, complementing information from X-rays and total ALP.¹⁶ For a child already diagnosed with kidney disease, a rising ALP usually signals worsening bone mineral disorder and may prompt adjustments in phosphate binders, vitamin D therapy, or dialysis prescriptions.

Medications That Raise ALP

Certain drugs prescribed to children can nudge ALP upward. The best-documented example is older antiepileptic medications. In a study of forty epileptic children on long-term anticonvulsant therapy, total serum ALP was elevated on average compared to age-matched controls, and the increase was driven specifically by the bone isoenzyme rather than the liver fraction.¹⁷ The proposed mechanism is that some anticonvulsants interfere with vitamin D metabolism, leading to increased bone turnover. Only a handful of individual values in that study exceeded the normal upper limit, so the effect is usually mild, but it is worth knowing about if your child takes seizure medications and a blood test comes back slightly off.

Endocrine Conditions

Thyroid overactivity speeds up bone remodeling, and that can show up as elevated bone ALP. A study of children with hyperthyroidism found that bone ALP levels at diagnosis were as high as the upper limits of the pubertal reference range. During treatment, levels dipped slightly at first, rose again transiently for a few months as bone metabolism recalibrated, and then gradually declined.¹⁸ Hyperparathyroidism is another, rarer, endocrine cause in children. And in juvenile idiopathic arthritis (JIA), the systemic form of the disease has been linked to high ALP in a majority of affected children, likely reflecting the widespread inflammatory effects on bone and growth.¹⁹

When to Worry About Bone Tumors

The fear that many parents carry when they see a high ALP result is cancer. While bone tumors are a real cause, they are rare compared to all the benign explanations above. Osteosarcoma, the most common primary malignant bone tumor in children and teenagers, does tend to produce elevated ALP because the tumor itself is made of abnormal bone-forming cells. One large study found that serum ALP had a sensitivity of about 53 percent and a specificity of about 90 percent for osteosarcoma when compared against other bone lesions, meaning that roughly half of children with osteosarcoma will have a noticeably elevated ALP, but a high ALP by itself is much more likely to be something else.²⁰

When osteosarcoma is present, ALP is useful as a prognostic marker. Elevated ALP at diagnosis correlates with larger tumor volume and is associated with worse overall survival.²⁰ Bone ALP specifically was found to be elevated in pediatric osteosarcoma patients at diagnosis compared to healthy controls.²¹ But to put this in perspective, a child with osteosarcoma almost always has other signs: persistent bone pain (often worse at night), a palpable mass, or a pathological fracture. An incidentally discovered high ALP in a child who looks and feels fine is overwhelmingly unlikely to be cancer.

Rare Genetic Causes

A small number of genetic syndromes are defined in part by persistently elevated ALP. The best characterized is hyperphosphatasia-mental retardation syndrome, also called Mabry syndrome. First described in 1970, it is an autosomal recessive condition caused by defects in the pathway that anchors ALP to cell surfaces. The enzyme breaks loose and accumulates in the bloodstream. Affected children have intellectual disability, seizures, and distinctive facial features alongside the biochemical finding of chronic hyperphosphatasia.²² Mutations in at least three genes in this pathway (PIGV, PIGO, and PGAP2) have been identified as causes.²³ These conditions are extremely rare but worth mentioning because they illustrate a scenario where a high ALP is not transient and is part of a broader developmental picture.

How Clinicians Sort It Out

Faced with an elevated ALP in a child, a doctor’s first step is usually the simplest: check the child’s age and look at age-appropriate reference ranges. A value that looks high compared to an adult reference range may be completely normal for a twelve-year-old boy in a growth spurt. If the number truly is above the pediatric range, the next move is to figure out whether the source is bone, liver, or something else. A few tools help with this:

GGT level: If GGT is elevated alongside ALP, the source is likely the liver or bile ducts. If GGT is normal, the elevation is probably coming from bone.
ALP isoenzyme testing: A heat-inactivation test or electrophoresis can separate bone, liver, and intestinal fractions of ALP. Research has confirmed that the bone isoenzyme is mainly responsible for the age-, sex-, and puberty-related variations in total ALP.²⁴
Calcium, phosphorus, and vitamin D: These help assess for rickets or other mineral-metabolism disorders.
Liver function panel: Other liver enzymes (ALT, AST) and bilirubin point toward hepatobiliary disease if they are abnormal alongside a high ALP.
Repeat testing: For a well-appearing child with an isolated ALP elevation, simply rechecking in four to eight weeks can confirm BTH if the level is dropping.

Imaging, bone biopsies, or genetic testing enter the picture only when the clinical scenario warrants it, such as persistent pain, growth failure, or neurological symptoms. For most children, the workup ends with a reassuring repeat blood draw showing the number on its way back down.

Why Adult Lab Ranges Cause Unnecessary Panic

A recurring source of parental anxiety is the way lab results are reported. Many hospital and clinic labs flag any ALP above the adult upper limit, which is usually somewhere around 120 to 150 U/L depending on the assay. A pubertal boy with a value of 500 U/L gets a red flag on the printout, the parent sees “HIGH” in bold, and worry sets in. But 500 U/L may be squarely within the normal range for a thirteen-year-old male. Pediatric reference intervals can reach 700 U/L or higher at certain ages.¹ Yet the adoption of age- and sex-specific cutoffs in everyday lab reporting remains inconsistent. If your child’s lab result is flagged as abnormal, it is always worth asking the pediatrician to compare the value against pediatric norms rather than accepting the lab’s automated adult-based flag at face value.

1
PubMed Central. Serum Alkaline Phosphatase Levels in Healthy Children and Evaluation of Alkaline Phosphatase z-scores in Different Types of Rickets
2
Bone. Pediatric reference values of alkaline phosphatase: Analysis from a German population-based cohort and influence of anthropometric and blood parameters
3
PubMed Central. A case series of benign transient hyperphosphatasemia from a pediatric endocrinology reference health facility in Turkey
4
Korean Journal of Pediatrics. Benign Transient Hyperphosphatasemia of Infancy and Childhood
5
PubMed. Benign transient hyperphosphatasaemia in infants: Clinical series
6
PubMed Central. Elevated Alkaline Phosphatase in Children: An Algorithm to Determine When a “Wait and See” Approach is Optimal
7
PubMed Central. Transient hyperphosphatasemia: Possible association with pediatric acute respiratory infection
8
FEMS Immunology & Medical Microbiology. Viral infection of infants and children with benign transient hyperphosphatasemia
9
PubMed Central. Alkaline phosphatase in clinical practice in childhood: Focus on rickets
10
Medical Journal of Babylon. Correlation of Bilirubin and Alkaline Phosphatase in Infantile Patients with Cholestasis
11
PubMed. Bone disease in infants and children with hepatobiliary disease
12
PubMed. Elevated Alkaline Phosphatase in Infants With Parenteral Nutrition-Associated Liver Disease Reflects Bone Rather Than Liver Disease
13
PubMed. Decreased mucosal expression of intestinal alkaline phosphatase in children with coeliac disease
14
Clinical Biochemistry. A micro-technique for the assay of intestinal alkaline phosphatase. results in normal children and in children with celiac disease
15
PubMed. Association of parathormone and alkaline phosphatase with bone turnover and mineralization in children with CKD on dialysis: effect of age, gender, and race
16
Nephrology Dialysis Transplantation. Bone alkaline phosphatase in children with chronic renal failure
17
PubMed. Serum alkaline phosphatase isoenzymes in epileptic children receving anticonvulsant drugs
18
J-STAGE (Clinical Pediatric Endocrinology). Bone Mineral Density and Bone Metabolic Markers in Children with Hyperthyroidism Before and During Treatment
19
Konuralp Medical Journal. The Importance of 25 Hydroxyvitamin D Level Monitoring in Children Diagnosed with Juvenile Idiopathic Arthritis
20
PubMed Central. Reassessment of alkaline phosphatase as serum tumor marker with high specificity in osteosarcoma
21
PubMed Central. The levels of bone alkaline phosphatase (BALP) and soluble epidermal growth factor receptor-2 (ECD/HER-2) in pediatric patients with osteosarcoma during clinical treatment
22
PubMed. Neurogenetic Aspects of Hyperphosphatasia in Mabry Syndrome
23
European Journal of Human Genetics. Delineation of PIGV mutation spectrum and associated phenotypes in hyperphosphatasia with mental retardation syndrome
24
Clinical Chemistry. Total bone and liver alkaline phosphatases in plasma: biological variations and reference limits